IL1B and type 1 diabetes mellitus: This might reduce the induction of MHC-I and T cell chemoattractants, however, it would not ablate them and in a genetically predisposed individual this may still be more than sufficient to help initiate and sustain T1D especially in combination with enhanced IL-1β production.